Leading the Fight Against
Low-Grade Serous Ovarian Cancer
THE FIRST US FOUNDATION DEDICATED TO FUNDING LGSOC RESEARCH
Why STAAR?
STAAR stands for SURVIVE. THRIVE. ADVOCATE. ADVANCE RESEARCH.​
STAAR Low-Grade Serous Ovarian Cancer was founded in 2020 when three women facing low-grade serous ovarian cancer recognized the urgent need for dedicated funding and support—a need unmet by the larger charities.​​
​The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (about 5% of ovarian cancer cases) and extremely underfunded ovarian cancer.
We fund research to provide better outcomes for people with LGSOC.
We support the LGSOC community with resources and a place to connect.
100% volunteer-run means more of every dollar goes directly to our mission.
STAAR is the first U.S. charity focused on funding LGSOC research.
LGSOC Disproportionately Affects Younger Women
​Today.com recently featured a story about STAAR board member Emma Schlamm, who first experienced symptoms of LGSOC when she was 25. Read her story here.
Advancing Research
To Improve Outcomes for LGSOC
Low-grade serous ovarian cancer (LGSOC) is a rare and understudied disease, leaving patients with limited treatment options. STAAR Low-Grade Serous Ovarian Cancer Foundation is the first U.S. nonprofit solely dedicated to funding LGSOC research.We work directly with leading scientists, research institutions, and medical experts to:
​
-
Fund groundbreaking studies that explore new treatment approaches
-
Drive collaboration between researchers and clinicians for faster discoveries
-
Advocate for increased investment in LGSOC research
Although LGSOC is a distinct and understudied form of ovarian cancer, it receives only a fraction of the research funding needed to develop life-saving treatments. STAAR is changing that by prioritizing research grants that directly impact patient survival and quality of life.
Our Partnership with the Low-Grade Serous Ovarian Cancer Initiative
Formerly known as Cure Our Ovarian Cancer, the Low-Grade Serous Ovarian Cancer Initiative was founded in New Zealand in 2018, blazing a trail as the world's first nonprofit dedicated to low-grade serous ovarian cancer (LGSOC).
Through our partnership, we amplify our impact—funding groundbreaking research and providing vital resources to those affected by LGSOC. Together, we’re building a stronger community, sharing knowledge, and fostering hope.
Despite LGSOC being rare but life-altering, research funding remains extremely limited. STAAR is working to change that by funding critical studies that lead to better treatments and improved outcomes.